DI SEBASTIANO, PIERLUIGI
 Distribuzione geografica
Continente #
NA - Nord America 5.308
EU - Europa 4.390
AS - Asia 3.136
SA - Sud America 454
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 13.369
Nazione #
US - Stati Uniti d'America 5.224
RU - Federazione Russa 1.710
SG - Singapore 1.550
CN - Cina 675
IE - Irlanda 487
IT - Italia 442
BR - Brasile 376
SE - Svezia 338
UA - Ucraina 336
VN - Vietnam 333
DE - Germania 328
GB - Regno Unito 287
TR - Turchia 183
FR - Francia 141
IN - India 125
FI - Finlandia 117
HK - Hong Kong 61
BD - Bangladesh 48
CA - Canada 42
AR - Argentina 40
AT - Austria 36
PL - Polonia 32
JP - Giappone 30
MX - Messico 28
NL - Olanda 26
ZA - Sudafrica 24
BE - Belgio 23
IQ - Iraq 21
ES - Italia 17
CZ - Repubblica Ceca 15
PK - Pakistan 14
KR - Corea 11
CO - Colombia 10
MA - Marocco 9
IL - Israele 8
EC - Ecuador 7
EG - Egitto 7
EU - Europa 7
KE - Kenya 7
LT - Lituania 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
ID - Indonesia 6
JO - Giordania 6
PY - Paraguay 6
RO - Romania 6
AU - Australia 5
EE - Estonia 5
OM - Oman 5
SA - Arabia Saudita 5
VE - Venezuela 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
AM - Armenia 3
AO - Angola 3
CL - Cile 3
DZ - Algeria 3
ET - Etiopia 3
IR - Iran 3
KG - Kirghizistan 3
MY - Malesia 3
PE - Perù 3
UY - Uruguay 3
DK - Danimarca 2
GL - Groenlandia 2
HN - Honduras 2
HU - Ungheria 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
MD - Moldavia 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LY - Libia 1
ME - Montenegro 1
Totale 13.354
Città #
Singapore 1.176
Chandler 842
San Jose 533
Ashburn 492
Dublin 482
Jacksonville 461
Dallas 265
Princeton 224
Beijing 211
Southend 157
Los Angeles 132
Munich 131
Wilmington 121
Santa Clara 120
Ho Chi Minh City 106
Izmir 93
Hanoi 88
Chieti 85
Nanjing 83
Moscow 80
Dearborn 75
Altamura 72
New York 68
The Dalles 67
Helsinki 57
Hong Kong 53
Cambridge 52
Council Bluffs 49
Washington 49
Ann Arbor 46
Buffalo 46
Tongling 45
Boardman 41
Redondo Beach 38
Woodbridge 35
Pescara 34
São Paulo 30
Tokyo 29
Warsaw 29
Houston 27
Vienna 27
Denver 26
Hefei 26
Brussels 22
Nanchang 22
Orem 22
Frankfurt am Main 21
Brooklyn 20
Boston 19
Chicago 19
London 19
Nuremberg 19
Montreal 18
Johannesburg 17
Manchester 17
Rome 17
Amsterdam 16
Dong Ket 16
Falls Church 16
Seattle 16
Shenyang 16
Stockholm 16
Atlanta 15
Da Nang 15
Chennai 14
Tianjin 14
Brno 13
Poplar 13
San Francisco 13
Edinburgh 12
Kunming 12
Pune 12
Grevenbroich 11
Mexico City 11
Milan 11
Rio de Janeiro 11
Toronto 11
Vittuone 11
Baghdad 10
Charlotte 10
Haiphong 10
Jiaxing 10
Phoenix 10
Seoul 10
Hebei 9
Istanbul 9
Mumbai 9
Norwalk 9
Belo Horizonte 8
Brasília 8
Curitiba 7
Fairfield 7
Lanciano 7
Nairobi 7
Ninh Bình 7
Turku 7
Amman 6
Ancona 6
Biên Hòa 6
Campinas 6
Totale 7.628
Nome #
A modified fast-track program for pancreatic surgery: A prospective single-center experience 797
A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: Influence on borderline resectable 776
Developing a Decision-making Model Based on an Interdisciplinary Oncological Care Group for the Management of Colorectal Cancer 271
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 206
Totally laparoscopic complete mesocolon excision for splenic flexure cancer. A single institution experience 174
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 169
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages 163
[Laparoscopic adrenalectomy: analysis of 65 cases] 160
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells 153
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 152
Batimastat, A Matrix Metalloproyeinase inhibitor accellerates Healing in Rat Experimental Colitis 150
MICROSATELLITE ALTERATIONS IN PANCREATIC CARCINOMA 149
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 148
Beneficial effects of BB-94, a matrix metalloproteinase inhibitor, in rat experimental colitis 148
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 146
[Carcinoma of the male breast. Our experience]. 142
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 142
Beneficial Effects of Batimastat (bb-94), a Matrix Metalloproteinase Inhibitor, in Rat Experimental Colitis 139
Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer 139
Extracorporeal versus intracorporeal anastomosis after laparoscopic right hemicolectomy: cost-effectiveness analysis 135
MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer 133
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 131
Full Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients 130
A surgical department for intensified care 128
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 126
Totally laparoscopic complete mesocolon excision for splenic flexure cancer 125
Appendicitis: the role of nerves in pain generation 124
How we do it: totally laparoscopic complete mesocolon excision for splenic flexure cancer 121
Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy 121
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients 116
BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. 115
Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-κB in chronic pancreatitis 115
Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers 114
Time-qualified patterns of variation of PPAR γ, DNMT1, and DNMT3B expression in pancreatic cancer cell lines 113
Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: A meta-analysis of prospective studies 113
Growth-associated protein-43 and protein gene-product 9.5 innervation in human pancreas: changes in chronic pancreatitis 113
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes 113
Mirna expression profiles identify drivers in colorectal and pancreatic cancers 113
Interleukin 8 gene expression is increased in patients with chronic pancreatitis (pubbl. su Digestion). 111
Espressione del Connective Tissue Growth Factor (CTGF) nel cancro pancreatico 111
Endoscopic therapy for type B surgical biliary injury in a patient with short cystic duct. 110
Alterations of dna-repeats in pancreatic cancer 110
Correlations among PPARγ, DNMT1, and DNMT3B expression levels and pancreatic cancer 109
Combined therapy in pancreatic cancer 108
The Pituitary Adenylate Cyclase-Activating Polypeptide Pathway is Activated in Human Chronic Pancreatitis. 108
Laparoscopic Versus Open Hartmann Reversal: A Case-Control Study 107
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients 107
Alterations of dna-repeats in pancreatic cancer 106
Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium 106
TRANSFORMING GROWTH FACTOR-BETA PATHWAY IS ACTIVATED IN CHOLECYSTOLITHIASIS 105
Influenza dei neurotrasmettitori algogeni sulla crescita cellulare nel cancro del pancreas 104
Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation 101
Neuroimmune appendicitis: a new pathological entity? 100
Cathepsins and pancreatic cancer: The 2012 update. 100
Support vector machine based on microRNA expression profiles to predict histological origin of ampullary carcinoma case report of a patient affected from adenocarcinoma of the papilla of vater with lynch syndrome 99
Substance P and neprilysin in chronic pancreatitis 99
Determinant-based classification of acute pancreatitis severity: International multidisciplinary classification of acute pancreatitis severity: The 2013 German Edition [Einteilung des Schweregrads der akuten Pankreatitis: Internationale, multidisziplinäre klinische Klassifikation auf Basis pathogenetischer Determinanten: Deutsche Version 2013] 99
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 99
Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients 98
Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: Single centre experience 98
Haemorrhoids and transient receptor potential vanilloid 1 98
Changes in cytokine but not tachynin gene expression in patients with chronic pancreatitis 97
SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation 97
Chronic pancreatitis: The perspective of pain generation by neuroimmune interaction 96
MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma 96
Expression of interleukin-8 and substance P in human chronic pancreatitis 94
Mechanism of pain in chronic pancreatitis 93
Differential expression of connective tissue growth factor in inflammatory bowel disease. 93
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. 93
Mapping of Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer 92
Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly 91
Chemokine receptor CXCR4: Role in gastrointestinal cancer 91
Transforming growth factor-βs and their signaling receptors are coexpressed in Crohn's disease 91
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management 91
Desmoplastic reaction influences pancreatic cancer growth behavior 90
Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: A systematic analysis of benefits and associated risks 90
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial 90
Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease 90
Italian consensus guidelines for chronic pancreatitis 90
Combined modality treatments in pancreatic cancer 90
PI3K-gamma upregulation promotes proliferation and AKT activation in pancreatic cancer 89
The role of extended resection in pancreatic adenocarcinoma: Is there good evidence-based justification? 89
Pathogenesis of pain in chronic pancreatitis 88
The Complex Network between Inflammation and Colorectal Cancer: A Systematic Review of the Literature 87
International Multidisciplinary Classification of Acute Pancreatitis Severity: The 2013 Spanish Edition 87
Changes of protein gene product 9.5 (PGP 9.5) immunoreactive nerves in inflamed appendix 87
Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases 87
REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives. 87
The techniques of duodenum preserving head resection of the pancreas in the treatment of chronic pancreatitis 86
The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis 85
Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels 83
Laparoendoscopic Rendezvous: An Effective and Safe Approach in the Management of Cholecysto-Choledocholithiasis in Selected Patients 83
Key Role of Phosphoinositide 3-kinase Class IB in Pancreatic Cancer. 82
Neurokinin-2 receptor levels correlate with intensity, frequency, and duration of pain in chronic pancreatitis 82
Immune cells infiltration and the expression of growth associated protein-43 expression correlate with pain in chronic pancreatisis 81
Phosphoinositide 3-Kinase Class IB plays a key role in human pancreatic cancer 79
Immune cell infiltration and Growth associated protein-43 correlate with pain in chronic pancreatitis. 78
Cronic pancreatitis: evidence for neurogenic inflammation 78
Phosphatidylserine receptor in chronic pancreatitis: Evidence for a macrophage independent role 77
Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer 77
Totale 12.443
Categoria #
all - tutte 51.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 91 16 41
2021/2022595 25 28 16 99 32 10 4 38 36 5 73 229
2022/20232.049 200 312 123 269 143 366 99 183 220 24 76 34
2023/2024904 58 35 81 26 80 300 157 58 1 33 6 69
2024/20252.106 114 349 239 81 65 117 125 140 269 81 248 278
2025/20265.547 368 172 461 471 498 320 872 288 1.803 294 0 0
Totale 13.876